Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

NCT: NCT07541404 · RECRUITING

NCT IDNCT07541404
StatusRECRUITING
Start Date2026-08-13
SponsorArsenal Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma (SDH) adjunctive to surgery.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑